Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1981 Mar;78(3):1828–1832. doi: 10.1073/pnas.78.3.1828

Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.

J D Lambris, N J Dobson, G D Ross
PMCID: PMC319228  PMID: 6101236

Abstract

A glycoprotein binding complement component C3d was isolated from media used for culture of Raji human lymphoblastoid cells. Analysis by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and gas/liquid chromatography indicated that the C3d-binding glycoprotein consisted of a single polypeptide chain with extensive intrachain disulfide bonds, a molecular weight of 72,000, and several different bound carbohydrates. Several lines of evidence indicated that this medium-derived C3d-binding protein originated from membrane complement receptor type two (CR2, the C3d receptor), presumably shed during membrane turnover. The C3d-binding protein bound to sheep erythrocytes coated with C3d (EC3d) but not to sheep erythrocytes coated with C3b (EC3b). Antisera, prepared by immunization with the purified C3d-binding glycoprotein, inhibited lymphocyte rosette formation with EC3d but not with EC3b. Analysis by sodium dodecyl sulfate gel electrophoresis of the radiolabeled and solubilized lymphocyte antigens reactive with the anti-C3d-binding protein sera revealed a single-chain cell-surface protein of molecular weight 72,000 that was apparently identical to the isolated C3d-binding protein. Parallel assay of lymphocytes for Cr2 by direct immunofluorescence with F(ab')2 anti-C3d-binding protein (anti-CR2) and rosette formation with EC3d indicated that both assays had the same specificity and nearly the same sensitivity. With both systems CR2 expression was limited to B cells, and was undetectable on T cells, monocytes, or neutrophils.

Full text

PDF
1828

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dierich M. P., Reisfeld R. A. C3 receptors on lymphoid cells: isolation of active membrane fragments and solubilization of receptor complexes. J Immunol. 1975 Jun;114(6):1676–1682. [PubMed] [Google Scholar]
  2. Dobson N. J., Lambris J. D., Ross G. D. Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies. J Immunol. 1981 Feb;126(2):693–698. [PubMed] [Google Scholar]
  3. Ehlenberger A. G., Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med. 1977 Feb 1;145(2):357–371. doi: 10.1084/jem.145.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fearon D. T., Austen K. F. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1683–1687. doi: 10.1073/pnas.74.4.1683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fearon D. T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med. 1980 Jul 1;152(1):20–30. doi: 10.1084/jem.152.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fox A., Schwab J. H., Cochran T. Muramic acid detection in mammalian tissues by gas-liquid chromatography-mass spectrometry. Infect Immun. 1980 Aug;29(2):526–531. doi: 10.1128/iai.29.2.526-531.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  8. Lambris J. D., Dobson N. J., Ross G. D. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin. J Exp Med. 1980 Dec 1;152(6):1625–1644. doi: 10.1084/jem.152.6.1625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lambris J., Papamichail M. A method for analysing lymphocyte surface antigens. J Immunol Methods. 1980;34(4):287–293. doi: 10.1016/0022-1759(80)90101-5. [DOI] [PubMed] [Google Scholar]
  10. Ly I. A., Mishell R. I. Separation of mouse spleen cells by passage through columns of sephadex G-10. J Immunol Methods. 1974 Aug;5(3):239–247. doi: 10.1016/0022-1759(74)90108-2. [DOI] [PubMed] [Google Scholar]
  11. March S. C., Parikh I., Cuatrecasas P. A simplified method for cyanogen bromide activation of agarose for affinity chromatography. Anal Biochem. 1974 Jul;60(1):149–152. doi: 10.1016/0003-2697(74)90139-0. [DOI] [PubMed] [Google Scholar]
  12. Reynolds H. Y., Atkinson J. P., Newball H. H., Frank M. M. Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol. 1975 Jun;114(6):1813–1819. [PubMed] [Google Scholar]
  13. Ross G. D. Analysis of the different types of leukocyte membrane complement receptors and their interaction with the complement system. J Immunol Methods. 1980;37(3-4):197–211. doi: 10.1016/0022-1759(80)90307-5. [DOI] [PubMed] [Google Scholar]
  14. Ross G. D., Jarowski C. I., Rabellino E. M., Winchester R. J. The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils. J Exp Med. 1978 Mar 1;147(3):730–744. doi: 10.1084/jem.147.3.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ross G. D., Polley M. J. Assay for the two different types of lymphocyte complement receptors. Scand J Immunol. 1976 Jun;Suppl 5:99–111. doi: 10.1111/j.1365-3083.1976.tb03861.x. [DOI] [PubMed] [Google Scholar]
  16. Ross G. D., Polley M. J., Rabellino E. M., Grey H. M. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med. 1973 Oct 1;138(4):798–811. doi: 10.1084/jem.138.4.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ross G. D., Polley M. J. Specificity of human lymphocyte complement receptors. J Exp Med. 1975 May 1;141(5):1163–1180. doi: 10.1084/jem.141.5.1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ross G. D., Winchester R. J., Rabellino E. M., Hoffman T. Surface markers of complement receptor lymphocytes. J Clin Invest. 1978 Nov;62(5):1086–1092. doi: 10.1172/JCI109214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rosso di San Secondo V. E., Meroni P. L., Fortis C., Tedesco F. Study on the turnover of the receptor for the third component of complement on human lymphoid cells. J Immunol. 1979 May;122(5):1658–1662. [PubMed] [Google Scholar]
  20. Sundsmo J. S., Müller-Eberhard H. J. Neoantigen of the complement membrane attack complex of cytotoxic human peripheral blood lymphocytes. J Immunol. 1979 Jun;122(6):2371–2378. [PubMed] [Google Scholar]
  21. Tack B. F., Dean J., Eilat D., Lorenz P. E., Schechter A. N. Tritium labeling of proteins to high specific radioactivity by reduction methylation. J Biol Chem. 1980 Sep 25;255(18):8842–8847. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES